ID   HMS-1
AC   CVCL_UD56
DR   Wikidata; Q94213294
RX   PubMed=8606488;
RX   PubMed=8946227;
RX   PubMed=9815584;
CC   Doubling time: 24-36 hours (PubMed=8946227).
CC   Derived from site: In situ; Salivary gland, parotid gland, myoepithelium; UBERON=UBERON_0035076.
DI   NCIt; C5941; Parotid gland adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UD57 ! HMS-XC
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
RX   PubMed=8606488;
RA   Sternlicht, Mark D.
RA   Safarians, Suzi
RA   Rivera, Steven P.
RA   Barsky, Sanford H.
RT   "Characterizations of the extracellular matrix and proteinase
RT   inhibitor content of human myoepithelial tumors.";
RL   Lab. Invest. 74:781-796(1996).
//
RX   PubMed=8946227; DOI=10.1007/BF02722982;
RA   Sternlicht, Mark D.
RA   Safarians, Suzi
RA   Calcaterra, Thomas C.
RA   Barsky, Sanford H.
RT   "Establishment and characterization of a novel human myoepithelial
RT   cell line and matrix-producing xenograft from a parotid basal cell
RT   adenocarcinoma.";
RL   In Vitro Cell. Dev. Biol. Anim. 32:550-563(1996).
//
RX   PubMed=9815584;
RA   Sternlicht, Mark D.
RA   Kedeshian, Paul
RA   Shao, Zhi-Ming
RA   Safarians, Suzi
RA   Barsky, Sanford H.
RT   "The human myoepithelial cell is a natural tumor suppressor.";
RL   Clin. Cancer Res. 3:1949-1958(1997).
//